Involvement of dopamine D3 and D4 receptors in the discriminative stimulus properties of cocaine in the rat

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 27, Issue 9, 2005, Pages 645-649

  Ukai, Makoto ^a   Mitsunaga, H ^a  

^a MEIJO UNIVERSITY   (Japan)

Author keywords

Cocaine; Discriminative stimulus properties; Dopamine receptor; GR103691; L745870; R(+) 7 OH DPAT; Rat

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; 4' ACETYL N [4 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]BUTYL]BIPHENYL 4 CARBOXAMIDE; BROMOCRIPTINE; COCAINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ARTICLE; DISCRIMINATIVE STIMULUS; MALE; NONHUMAN; RAT; TRAINING;

ANIMALS; BIPHENYL COMPOUNDS; BROMOCRIPTINE; COCAINE; DISCRIMINATION (PSYCHOLOGY); DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; MALE; PIPERAZINES; PYRIDINES; PYRROLES; RATS; RATS, INBRED F344; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; TETRAHYDRONAPHTHALENES;

EID: 29244483992     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2005.27.9.939341     Document Type: Article

References (19)

1. Holtzman, S.G. Drug discrimination studies. Drug Alcohol Depend 1985, 14: 263-82.
2. Ukai, M. Drug discrimination and in vivo pharmacology of drugs. Methods Find Exp Clin Pharmacol 1996, 18(Suppl. A): 59-65.
3. Johanson, C.E., Fischman, M.W. The pharmacology of cocaine related to its abuse. Pharmacol Rev 1989, 41: 3-52.
4. Kleven, M.S., Anthony, E.W., Woolverton, W.L. Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 1990, 254: 312-7.
5. Callahan, P.M., Appel, J.B., Cunningham, K.A. Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology 1991, 103: 50-5.
6. Spealman, R.D., Bergman, J., Madras, B.K., Melia, K.F. Discriminative stimulus effects of cocaine in squirrel monkeys: Involvement of dopamine receptor subtypes. J Pharmacol Exp Ther 1991, 258: 945-53.
7. Vorel, S.R., Ashby, C.R., Jr., Paul, M. et al. Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci 2002, 22: 9595-603.
8. Mattingly, B.A., Caudill, A., Abel, M. Differential effects of 7-OH-DPAT on the development of behavioral sensitization to apomorphine and cocaine. Pharmacol Biochem Behav 2001, 68: 417-26.
9. Lamas, X., Negus, S.S., Nader, M.A., Mello, N.K. Effects of the putative dopamine D3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline. Psychopharmacology 1996, 124: 306-14.
10. Costanza, R.M., Terry, P. The dopamine D4 receptor antagonist L-745,870: Effects in rats discriminating cocaine from saline. Eur J Pharmacol 1998, 345: 129-32.
11. Ukai, M., Mori, E., Kameyama, T. Discriminative stimulus properties of cocaine in the rat using two-choice discrete-trial avoidance paradigm. Pharmacol Biochem Behav 1993, 44: 907-11.
12. Patel, S., Freedman, S., Chapman, K.L. et al. Biological profile of L-745, 870, a selective antagonist with high affinity for the dopamine D4 receptor. J Pharmacol Exp Ther 1997, 283: 636-47.
13. Audinot, V., Newman-Tancredi, A., Gobert, A. et al. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S14297, nafadotride, GR103,691 and U99194. J Pharmacol Exp Ther 1998, 287: 187-97.
14. Ukai, M., Holtzman, S.G. Morphine-like discriminative stimulus effects of opioid peptides: Possible modulatory role of D-Ala2-D-Leu5-enkephalin (DADL) and dynorphin A (1-13). Psychopharmacology 1988, 94: 32-7.
15. Ritz, M.C., Lamb, R.J., Goldberg, S.R., Kuhar, M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987, 237: 1219-23.
16. Sokoloff, P., Giros, B., Martres, M.P., Bouthenet, M.L., Schwartz, J.C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1990, 347: 146-51.
17. Svensson, K., Carlsson, A., Huff, R.M., Kling-Petersen, T., Waters, N. Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors. Eur J Pharmacol 1994, 263: 235-43.
18. Millan, M.J., Peglion, J.L., Vian, J. et al. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297. 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy. J Pharmacol Exp Ther 1995, 275: 885-98.
19. Millan, M.J., Girardon, S., Monneyron, S., Dekeyne, A. Discriminative stimulus properties of the dopamine D3 receptor agonists, PD128,907 and 7-OH-DPAT: A comparative characterization with novel ligands at D3 versus D2 receptors. Neuropharmacology 2000, 39: 586-98.